MedTrace Logo

Efficacy of Pregabalin in Migraine Prevention

NCT00447369 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2008-05-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of pregabalin in comparison with sodium valproate in migraine prevention with a randomized blinded crossover study.

Conditions

  • Migraine Disorders

Interventions

DRUG

Pregabalin

DRUG

sodium valproate

Sponsors & Collaborators

  • Hospital Militar del General Luis Felipe Brieba Aran

    lead OTHER

Principal Investigators

  • Norberto Bilbeny, MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Completion
2008-03-31

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00447369 on ClinicalTrials.gov